Amgen Sues Pfizer Over US Pegfilgrastim Biosimilar

Meanwhile aBLA For Pegfilgrastim Is Being Reviewed By FDA

 
• By Akriti Seth
  
Lwsuit
Amgen’s lawsuit alleges infringement of a protein-purifying patent • Source: Shutterstock

More from Biosimilars

More from Products